Literature DB >> 7917854

The absence of anti-neutrophil cytoplasmic antibodies in patients with Henoch-Schönlein purpura.

W L Robson1, A K Leung, R C Woodman.   

Abstract

Sera from 14 patients with acute Henoch-Schönlein purpura (HSP) and 5 patients with a past history of HSP were assessed using a immunofluorescence technique for the presence of IgG, IgA, and IgM anti-neutrophil cytoplasmic antibodies (ANCA). There was no evidence of IgG, IgA, or IgM ANCA in the sera of these patients. These results suggest that ANCA are not involved in the pathogenesis of HSP.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7917854     DOI: 10.1007/bf00866339

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  29 in total

1.  Antineutrophil cytoplasm antibodies in Kawasaki disease.

Authors:  C O Savage; J Tizard; D Jayne; C M Lockwood; M J Dillon
Journal:  Arch Dis Child       Date:  1989-03       Impact factor: 3.791

2.  Classic and perinuclear anti-neutrophil cytoplasm antibodies and antimyeloperoxidase antibodies in rapidly progressive glomerulonephritis.

Authors:  C Rollino; D Roccatello; R Coppo; E Menegatti; B Basolo; G Giraudo; G Martina; G Piccoli
Journal:  Am J Nephrol       Date:  1991       Impact factor: 3.754

3.  IgA antibodies directed against cytoplasmic antigens of polymorphonuclear leukocytes in patients with Henoch-Schoenlein purpura.

Authors:  A W vd Wall Bake; S Lobatto; L Jonges; M R Daha; L A van Es
Journal:  Adv Exp Med Biol       Date:  1987       Impact factor: 2.622

Review 4.  Specificity and pathogenicity of antineutrophil cytoplasm antibodies.

Authors:  C M Lockwood
Journal:  Exp Nephrol       Date:  1993 Jan-Feb

5.  Anti-alpha-galactosyl antibodies and immune complexes in children with Henoch-Schönlein purpura or IgA nephropathy.

Authors:  J C Davin; M Malaise; J Foidart; P Mahieu
Journal:  Kidney Int       Date:  1987-05       Impact factor: 10.612

6.  IgA antineutrophil cytoplasmic antibody in Henoch-Schönlein purpura.

Authors:  F T Saulsbury; P R Kirkpatrick; W K Bolton
Journal:  Am J Nephrol       Date:  1991       Impact factor: 3.754

7.  IgA rheumatoid factor in Henoch-Schönlein purpura.

Authors:  F T Saulsbury
Journal:  J Pediatr       Date:  1986-01       Impact factor: 4.406

8.  Antineutrophil cytoplasmic antibodies in IgA nephropathy and Henoch-Schönlein purpura.

Authors:  D J O'Donoghue; P Nusbaum; L H Noel; L Halbwachs-Mecarelli; P Lesavre
Journal:  Nephrol Dial Transplant       Date:  1992       Impact factor: 5.992

9.  How are antineutrophil cytoplasmic autoantibodies detected?

Authors:  J Wieslander
Journal:  Am J Kidney Dis       Date:  1991-08       Impact factor: 8.860

10.  Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis.

Authors:  R J Falk; J C Jennette
Journal:  N Engl J Med       Date:  1988-06-23       Impact factor: 91.245

View more
  4 in total

1.  Circulating adhesion molecules ICAM-1, E-selectin, and von Willebrand factor in Henoch-Schönlein purpura.

Authors:  O Söylemezoglu; N Sultan; T Gursel; N Buyan; E Hasanoglu
Journal:  Arch Dis Child       Date:  1996-12       Impact factor: 3.791

Review 2.  Adult-onset Henoch-Schonlein purpura with positive c-ANCA (anti-proteinase 3): case report and review of literature.

Authors:  Eman Boulis; Vikas Majithia; Robert McMurray
Journal:  Rheumatol Int       Date:  2010-10-21       Impact factor: 2.631

3.  Significance of antineutrophil cytoplasmic antibody in adult patients with Henoch-Schönlein purpura presenting mainly with gastrointestinal symptoms.

Authors:  Yan Zhang; Yong-Kang Wu; Matthew-A Ciorba; Qin Ouyang
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

4.  The significance of IgA class of antineutrophil cytoplasmic antibodies (ANCA) in childhood Henoch-Schönlein purpura.

Authors:  Fatih Ozaltin; Aysin Bakkaloglu; Seza Ozen; Rezan Topaloglu; Umut Kavak; Mukaddes Kalyoncu; Nesrin Besbas
Journal:  Clin Rheumatol       Date:  2004-06-18       Impact factor: 2.980

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.